NCT02569736View on ClinicalTrials.gov

Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Arthritis, RheumatoidTocilizumabT-Lymphocytes, Helper-Inducer
Trial Locations (1)

33076

Rheumatology department - Bordeaux University Hospital, Bordeaux

Sponsors

Collaborators (1)

Chugai Pharma France
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Chugai Pharma France

INDUSTRY

lead

Association Aquitaine de Recherche Clinique en Rhumatologie

OTHER

NCT02569736 - Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation | Biotech Hunter | Biotech Hunter